Stempoint Capital »

Eliem Therapeutics shares owned by Stempoint Capital

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.7M 743k 13.04